Copyright License
Clear licensing terms that protect author rights and accelerate open science reuse.
Journal at a Glance
ISSN: 2577-137X
DOI Prefix: 10.14302/issn.2577-137X
License: CC BY 4.0
Peer reviewed open access journal
Scope Alignment
Immunization policy, vaccine development, safety monitoring, immunogenicity, delivery systems, and global vaccine equity. We prioritize evidence that strengthens public health outcomes and informs immunization programs.
Publishing Model
Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.
All JI articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows broad reuse while ensuring authors receive proper attribution.
Authors retain copyright and grant JI the right to publish, distribute, and archive the work.
Authors retain copyright and control over how their work is reused in future scholarship or teaching. The CC BY license enables wide distribution while preserving attribution and citation integrity.
- Copyright ownership of the published article
- The right to reuse figures, tables, and text in future work
- Permission to deposit the final article in institutional repositories
- The ability to share the article on personal or lab websites
CC BY 4.0 allows reuse for research, policy, and educational purposes, including adaptation and translation. Users must credit the original authors and indicate if changes were made.
- Reuse, adapt, and build upon the work for any purpose
- Translate or incorporate content into public health materials
- Include the article in systematic reviews or meta analyses
- Text and data mining for research or policy insights
Reuse must include proper attribution to the authors, journal, year of publication, and DOI. Recommended attribution includes the article title, author names, journal name, year, and DOI.
- Link to the original article and DOI
- Indicate if changes were made
- Preserve citation details and author order
If your article includes third party figures, datasets, or copyrighted content, obtain permission from the rights holder and document it clearly. Materials not covered under CC BY should be labeled with appropriate credit lines.
For clinical images or program materials, ensure consent and permissions are documented.
Immunization studies are frequently used in guidelines, training manuals, and public health communications. CC BY licensing enables rapid reuse in these materials while preserving author attribution.
When creating derivative products, users should cite the journal and DOI so program teams can trace the original evidence.
Clear attribution maintains trust with community stakeholders.
Authors may share the final published version in institutional repositories or on personal websites. We encourage sharing with citation details and DOI links to preserve the scholarly record.
If you have questions about repository requirements or funder mandates, contact the editorial office for guidance.
Repository deposits should include the final published citation.
Use complete citations when reusing content, including the article title, author names, journal, year, and DOI. Clear attribution supports traceability for immunization stakeholders who rely on original evidence sources.
If content is adapted for guidelines or training materials, note the adaptation and retain the original citation details.
For translations, cite the original language source alongside the translated version.
Attribution should remain visible wherever the content is reused.
JI is committed to rigorous, transparent publishing in immunization research and program evaluation. We emphasize reproducible methods, clear reporting of vaccine outcomes, and ethical compliance across all article types.
The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].
We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in vaccine science, safety monitoring, and public health impact.
Questions About Licensing?
Contact the editorial office for guidance on copyright or reuse permissions.